Cell derived microparticles and vascular pregnancy complications A systematic and comprehensive review

Pregnancy showed a cMP increase. Differences in numbering and types of cMP in normal pregnancy, RM and PE have been demonstrated. Endothelial-derived cMP are increased in patients with antiphospholipid antibodies.

Like Comment

Authors

Jaume Alijotas-Reig, Ph.D., Carlos Palacio-García, M.D., Ph.D., Elisa Llurba, M.D., Ph.D., Miquel Vilardell-Tarrés, M.D., Ph.D.

Volume 99, Issue 2, Pages 441-449, February 2013

Abstract

Objective:

To assess current studies on the relationship between cell-derived microparticles (cMP) and recurrent miscarriages (RM) and preeclampsia (PE), and review the relationships between cMP and inflammatory and clot pathways, antiphospholipid antibodies (aPL), cytokines and pregnancy complications.

Design:

A comprehensive review of the literature from January 2000 to January 2012.

Setting:

Vall d’Hebron University Hospital.

Patient(s):

Women with recurrent miscarriages or preeclampsia, healthy non-pregnant and healthy pregnant women.

Intervention(s):

None.

Main Outcome Measure(s):

To compare cMP numbers and types among groups.

Result(s):

Platelet and endothelial cMP are increased in women with normal pregnancies compared with non-pregnant healthy women. Only five case-control studies regarding cMP and RM and 16 on cMP and preeclampsia were found to match our objective. Three of 5 articles referring to RM showed differences in cMP numbering, and 13 of 16 on cMP and preeclampsia showed differences in some type of cMP compared with controls.

Conclusion:

cMP were raised in normal pregnancy. Recurrent miscarriage appears to be related to endothelial and platelet cell activation and/or consumption. An increase in almost all cMP types was observed in PE. A relationship between cMP and endothelial activation and proinflammatory status seems to exist.

Read the full text at: http://www.fertstert.org/article/S0015-0282(12)02309-6/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.